Concord Drugs Ltd — Important, 17-02-2026: Company Update

Concord Drugs Limited has released its financial results for the quarter and nine months ended December 31, 2025. For the quarter, standalone revenue stood at ₹16.86 crore, with a profit of ₹0.21 crore. For the nine-month period, standalone revenue reached ₹40.32 crore, and profit was ₹0.52 crore. These unaudited results were reviewed by the Audit Committee and approved by the Board of Directors. The company's earnings per share were ₹0.16 for the quarter and ₹0.40 for the nine months.